Versor Investments LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Versor Investments LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$274,824
-9.1%
3,848
-23.8%
0.06%
-8.2%
Q3 2023$302,476
-16.9%
5,0480.0%0.06%
-3.2%
Q2 2023$363,9615,0480.06%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2024
NameSharesValueWeighting ↓
KNOTT DAVID M 1,199,766$130,078,630,00035.65%
CARDINAL CAPITAL MANAGEMENT LLC /CT 852,053$92,380,0005.34%
OBERWEIS ASSET MANAGEMENT INC/ 101,127$10,964,0003.08%
Timpani Capital Management LLC 68,160$7,390,0003.00%
ASHFORD CAPITAL MANAGEMENT INC 103,420$11,213,0002.64%
First Light Asset Management, LLC 56,818$6,160,0002.58%
Conestoga Capital Advisors, LLC 286,162$31,026,0002.51%
OAK RIDGE INVESTMENTS LLC 955,599$103,606,0002.48%
RK Capital 127,983$13,876,0002.42%
Nichols Asset Management LLC 93,170$10,101,0002.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders